De Novo Truncating Variants in the Last Exon of SEMA6B Cause Progressive Myoclonic Epilepsy.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
02 04 2020
Historique:
received: 20 11 2019
accepted: 19 02 2020
pubmed: 15 3 2020
medline: 12 5 2020
entrez: 15 3 2020
Statut: ppublish

Résumé

De novo variants (DNVs) cause many genetic diseases. When DNVs are examined in the whole coding regions of genes in next-generation sequencing analyses, pathogenic DNVs often cluster in a specific region. One such region is the last exon and the last 50 bp of the penultimate exon, where truncating DNVs cause escape from nonsense-mediated mRNA decay [NMD(-) region]. Such variants can have dominant-negative or gain-of-function effects. Here, we first developed a resource of rates of truncating DNVs in NMD(-) regions under the null model of DNVs. Utilizing this resource, we performed enrichment analysis of truncating DNVs in NMD(-) regions in 346 developmental and epileptic encephalopathy (DEE) trios. We observed statistically significant enrichment of truncating DNVs in semaphorin 6B (SEMA6B) (p value: 2.8 × 10

Identifiants

pubmed: 32169168
pii: S0002-9297(20)30053-7
doi: 10.1016/j.ajhg.2020.02.011
pmc: PMC7118575
pii:
doi:

Substances chimiques

SEMA6B protein, human 0
Semaphorins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

549-558

Informations de copyright

Copyright © 2020 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Références

Development. 2014 Oct;141(19):3709-20
pubmed: 25209245
Nat Genet. 2014 Sep;46(9):944-50
pubmed: 25086666
Nature. 2007 Jan 11;445(7124):168-76
pubmed: 17151600
Cell. 2018 Aug 9;174(4):999-1014.e22
pubmed: 30096314
Nucleic Acids Res. 2009 Jan;37(Database issue):D211-5
pubmed: 18940856
J Hum Genet. 2018 Dec;63(12):1223-1229
pubmed: 30258207
Gene Expr Patterns. 2012 Mar-Apr;12(3-4):117-22
pubmed: 22330030
Nat Neurosci. 2002 Dec;5(12):1294-301
pubmed: 12436113
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Nature. 2017 Feb 23;542(7642):433-438
pubmed: 28135719
Nature. 2018 Mar 29;555(7698):611-616
pubmed: 29562236
Genome Res. 2019 Feb;29(2):159-170
pubmed: 30587507
Nat Genet. 2019 Jan;51(1):88-95
pubmed: 30531870
Sci Rep. 2018 Jan 30;8(1):1845
pubmed: 29382872
Neuron. 2012 Nov 21;76(4):721-34
pubmed: 23177958
Neurosci Lett. 2017 Feb 22;641:70-76
pubmed: 28109776
Front Synaptic Neurosci. 2018 Apr 26;10:6
pubmed: 29760657
Nat Genet. 2019 Jan;51(1):106-116
pubmed: 30559488
Science. 2018 Apr 13;360(6385):176-182
pubmed: 29545511
Neuron. 2007 Jan 18;53(2):217-32
pubmed: 17224404
Mov Disord. 2011 Jul;26(8):1509-14
pubmed: 21506164
PLoS One. 2016 Jul 08;11(7):e0158686
pubmed: 27392094
Am J Hum Genet. 2017 Apr 6;100(4):650-658
pubmed: 28343630
PLoS One. 2013;8(1):e54166
pubmed: 23342097
Nat Cell Biol. 2004 Dec;6(12):1204-11
pubmed: 15543137
Neuroscience. 2005;131(3):759-68
pubmed: 15730879
Nature. 2015 Mar 12;519(7542):223-8
pubmed: 25533962
Curr Opin Neurobiol. 2009 Jun;19(3):263-74
pubmed: 19541473
Philos Trans A Math Phys Eng Sci. 2015 Mar 6;373(2036):
pubmed: 25624520
Semin Pediatr Neurol. 2019 Dec;32:100770
pubmed: 31813518
Am J Hum Genet. 2015 Apr 2;96(4):612-22
pubmed: 25817016
Cell. 2007 Jan 26;128(2):399-410
pubmed: 17254975
Semin Neurol. 2015 Jun;35(3):293-9
pubmed: 26060909
Brain. 1985 Mar;108 ( Pt 1):225-40
pubmed: 3919884
Cell Mol Life Sci. 2016 Apr;73(8):1609-22
pubmed: 26794845

Auteurs

Kohei Hamanaka (K)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Eri Imagawa (E)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Eriko Koshimizu (E)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Satoko Miyatake (S)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Jun Tohyama (J)

Department of Pediatrics, National Hospital Organization Nishi-Niigata Chuo National Hospital, Niigata 950-2085, Japan.

Takanori Yamagata (T)

Department of Pediatrics, Jichi Medical University, Tochigi 329-0498, Japan.

Akihiko Miyauchi (A)

Department of Pediatrics, Jichi Medical University, Tochigi 329-0498, Japan.

Nina Ekhilevitch (N)

The Genetics Institute, Rambam Health Care Campus, Haifa 3109601, Israel.

Fumio Nakamura (F)

Department of Biochemistry, Tokyo Women's Medical University, Tokyo 162-8666, Japan.

Takeshi Kawashima (T)

Department of Molecular Pharmacology and Neurobiology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Yoshio Goshima (Y)

Department of Molecular Pharmacology and Neurobiology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Ahmad Rithauddin Mohamed (AR)

Department of Pediatric Neurology Unit, Pediatric Institute, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.

Gaik-Siew Ch'ng (GS)

Department of Genetics, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia.

Atsushi Fujita (A)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Yoshiteru Azuma (Y)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Ken Yasuda (K)

Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.

Shintaro Imamura (S)

Reserch Center for Biochemistry and Food Technology, National Research Institute of Fisheries Science, Yokohama 236-8648, Japan.

Mitsuko Nakashima (M)

Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Hirotomo Saitsu (H)

Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka 431-3192, Japan.

Satomi Mitsuhashi (S)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Takeshi Mizuguchi (T)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Atsushi Takata (A)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Noriko Miyake (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.

Naomichi Matsumoto (N)

Department of Human Genetics, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan. Electronic address: naomat@yokohama-cu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH